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Background/aim: To compare the subjective level of pain in patients who underwent an ultrasound-guided percutaneous liver biopsy
(PLB) after either pericapsular anesthesia (PA) or subcapsular anesthesia (SA), based on the numeric rating scale (NRS).
Materials and methods: A total of 323 patients, mean age 51, range 21–82 years; 160 (49.5%) male, referred to the Interventional
Radiology Clinic of Kocaeli University Faculty of Medicine for image-guided PLB, between June 2019 and May 2020 were included
and randomized into two groups by anesthetic type; the first (n = 171) consisted of patients undergoing SA while the second (n = 152)
included patients undergoing PA. The intensity of pain at 0, 1, and 6 h after PLB was evaluated between the groups using NRS.
Results: At hours 0, 1, and 6, the median [range] NRS scores in the subcapsular and pericapsular groups were 2 [1–2] versus 3 [2–4]
(P < 0.001), 1 [0–1] versus 1 [1–2] (P < 0.001), and 0 [0–0] versus 1 [0–1] (P < 0.001), respectively. Subgroup analysis revealed that the
patients who underwent the subcostal procedure with subcapsular anesthesia reported the lowest pain scores and intercostal procedure
with pericapsular anesthesia reported the worst pain scores for each time point: 0 h 1 [1–2] versus 3 [3–4], P < 0.001; 1 h 1 [0–1] versus
1 [1–2], P < 0.001; and 6 h 0 [0–0] versus 0 [0–1], P < 0.001, respectively.
Conclusion: Subcapsular anesthesia is a well-tolerated procedure compared to a pericapsular procedure. Furthermore, the application
of a subcapsular anesthetic with a subcostal approach was reported to result in the lowest pain and greatest patient comfort.
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1. Introduction
Percutaneous liver biopsy (PLB) is a procedure that we
obtain a small piece of liver tissue by a needle inserted
into the liver through the skin, subcutaneous tissue,
and muscles, either with or without the guidance by
simultaneous imaging [1,2]. PLB is an essential procedure
in assessing chronic liver diseases and the differentiation
of primary or metastatic liver malignancies [3,4].
After the biopsy procedure, minor complications
such as pain and significant complications such as
pneumothorax, hemorrhage, and death may develop [5].
Although pain seems to be a minor complication, it may
affect the diagnosis and treatment in liver diseases by
affecting the patient’s willingness to have the procedure.
Previous studies have demonstrated moderate to severe
perception of pain after liver biopsy [2,6,7].
Pain is a sophisticated subjective experience. Pain
arising from the liver biopsy is believed to originate from
skin and liver capsule innervation [5]. In previous reports,

the patient’s age and sex, operator experience, route of
biopsy, size of the needle, number of needle passes, and
intravenous drug usage have been identified as factors that
lead to pain from liver biopsy [8,9].
Traditionally, pericapsular anesthesia is a commonly
used approach as a part of liver biopsy [10]. In our
institution, two techniques –subcapsular (SA) or
pericapsular (PA)– are used for the administration of a
local anesthetic. In the past, most of the liver biopsies in
our center were performed with PA. However, anecdotal
reports from patients indicated that the SA approach was
associated with less pain. This study aimed to compare the
levels of pain, as reported by patients undergoing PLB,
after either SA or PA local anesthesia.
2. Materials and methods
2.1. Patient selection
The study was designed as a cross-sectional single-center
study. All patients who were referred for liver parenchyma
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biopsy to the Interventional Radiology Clinic of Kocaeli
University Faculty of Medicine between June 2019 and
May 2020, and met the inclusion criteria were considered
for the study. Patients were randomly assigned to one of
the local anesthesia approaches, SA or PA.
Adults over 18 years old and with normal coagulation
parameters and agreeing to participate in the study
were included. Patients under the age of 18 and those
with abnormal coagulation test results (international
normalized ratio >1.5), low platelet count (<70.000/mm³),
dilatation of the biliary ducts, massive ascites, past liver
transplantation, and pregnancy were excluded from the
study.
2.2. Randomization
Patients were randomly assigned into two groups, liver
biopsy performed after PA (n = 152) and SA (n = 171).
A web-based randomization platform1 was used, and
randomization codes for either a PA or SA procedure
were placed in sequentially numbered, sealed envelopes in
the interventional radiology department. The radiologist
who performed the biopsy procedure was aware of
the approach, but the patients and the physician (CA)
evaluating the pain were blinded to the method.
2.3. Procedure
All PLB procedures were guided by ultrasound (US) and
were performed by a single experienced operator (OC)
with more than ten years’ experience. The operator had
achieved more than 100 PLBs using both the subcostal and
intercostal approaches before conducting this study. No
sedation procedure was administered before the process.
All the biopsy procedures were performed under an
aseptic field, using a 25-gauge needle and a total of 10 mL
of 1% lidocaine for anesthesia. In the PA group, 5 mL of
1% lidocaine was injected into subcutaneous tissue and
5 mL of 1% lidocaine to the liver’s periscapular area. In
the SA group, 5 mL of 1% lidocaine was injected into the
subcutaneous tissue, and the remaining 5 mL of 1% was
injected into the liver capsule.
Both PA and SA lidocaine injections were performed
under US-guidance, and vascular leakage was checked
by applying negative aspiration, before giving the local
anesthetic agent. The spread of the anesthetic agent
delivered to the subcapsular liver area was observed by the
US, as shown in Figures 1A and 1B.
PLB was performed using either an intercostal or
subcostal approach as appropriate for the intended biopsy
site. We performed the intercostal method from the right
lateral lower chest and the subcostal approach from the
epigastrium. After a small incision of less than 5 mm, we
performed freehand US-guided biopsy with an 18-gauge,
automated, cutting, biopsy needle (Magnum; C.R. Bard,
1

Covington, GA, USA). The throw of the cutting needle was
set at 22 mm, and if the specimen was judged inadequate
in size (≤15 mm in length), we repeated the biopsy
procedure at the same access site. After PLB, patients were
observed on the ward for 12 h with control of vital signs.
2.4. Pain assessment
The numeric rating scale is a scale designed to help
assess the extent of an individual’s pain and improve
communication regarding pain with health care providers.
In our study, we preferred NRS because of our experience
in using and evaluating in previous studies in our clinic
and ease of application. The level of pain was evaluated
with the numerical rating scale (NRS) immediately after
the procedure (pain score at 0 h), and after 1 h (pain score
at 1 h) and after 6 h (pain score at 6 h). Patients were asked
to rate their pain on a 10-point scale, where 0 represents
no pain, and 10 represents the worst pain that the patient
could imagine. NRS is a validated and reliable tool. The
pain scores were subdivided to achieve final ratings of 0–3
(score of 0 = 0; scores of 1–3 = 1; scores of 4–6 = 2; scores
of 7–10 = 3) as previously described [11].
A physician (CA) informed all the patients about NRS
before the biopsy procedure and asked patients to mark
the pain levels experienced at 0, 1, and 6 h by guiding
them and providing as much information as necessary.
2.5. Statistical analysis
Descriptive statistics for demographic characteristics
of the patients and features related to the procedure
were presented as frequency and percentage (%) for
categorical variables and mean with standard deviation
(mean ± SD) or median and interquartile range [median
(IQR = Q3–Q1)] according to the distribution of the
continuous variables. Demographic and clinical features
were compared between the subgroups using the Mann–
Whitney U test (Wilcoxon rank-sum test), independent
sample t-test, or chi-square test as appropriate. We
analyzed the relationship between the pain scores and the
duration of the procedure by Spearman’s rank correlation
coefficient. Kruskal–Wallis H test was used to assess the
pain scores between the subgroup analysis of the type of
anesthesia and the biopsy location. Dunn’s pairwise tests
were carried out with post hoc analysis using Mann–
Whitney U test. The p adjusted using the Bonferroni
correction.
The sample size was calculated to achieve 80% power
to detect 0.6 of a standard deviation difference in NRS
with an alpha of 0.05.
All statistical analyses were performed using SPSS,
version 20.0 software (IBM Corp., Armonk, NY, USA).
Two-sided p values less than 0.05 were considered
statistically significant (P < 0.05).
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3. Results
Final numbers in the PA and SA groups exceeded the
power calculation requirement at n = 152 and n =
171, respectively. The comparison of demographics of
population and features of procedure between the SA and
PA groups is summarized in Table 1.
Based on the previous reports suggesting the subcostal
approach was superior over intercostal, the pain scores
were analyzed after subgrouping for both the anesthesia
type and biopsy approach route. It resulted in there being
four subgroups: SA with the subcostal procedure (SA+SC),
SA with the intercostal procedure (SA+IC), PA with the
subcostal procedure (PA-SC), and PA with the intercostal
procedure (PA-IC). When the pain scores at 0, 1, and 6
h with subgroups were compared, there was a significant
difference in terms of reported pain (Table 2). The pairwise
comparison revealed that the PA-IC group reported the
worst pain scores while the SA-SC subgroup reported the
least pain at all time points, as shown in Figure 2.

There was no correlation between patient age and pain
scores in each anesthesia subgroup (data not shown).
There was a significant and positive correlation between
the duration of the procedure and pain scores at 0 h in
patients who underwent pericapsular anesthesia (Table 3).
4. Discussion
Liver biopsy is an essential diagnostic tool for evaluating
acute and chronic parenchymal liver diseases as well as
mass lesions [1,4]. As a result of therapeutic advances,
histological assessment has become a central aspect of
diagnosis and staging of the parenchymal liver diseases
[12]. Although the typical imaging pattern enables the
determination of liver metastasis and hepatocellular
carcinoma (HCC) with noninvasive diagnostic techniques
(CT or MRI), it can be a significant challenge to diagnose
nodules smaller than one centimeter in diameter in
cirrhotic liver parenchyma [4,13,14]. If imaging modalities
are not sufficient for diagnosis of HCC, histopathological

Figure 1. A) US image before the liver biopsy, the needle (white arrow), injected local anaesthetic agent under the liver capsule
(white star), liver parenchyma region to be biopsied (black star); B) US image during the liver biopsy. The biopsy needle has been
introduced through the anesthetized capsular area (bold white arrow).
Table 1. Comparison of the demographics of the population and features of the procedures
between subcapsular and pericapsular anesthesia.
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Subcapsular
n = 171

Pericapsular
n = 152

P

Female, n (%)

91 (53.2)

80 (52.6)

0.294

Age, yrs

54 ± 17.3

50.7 ± 16.8

0.089

Biopsy location (subcostal), n (%)

37 (21.6%)

45 (29.6%)

0.101

Pain score at 0. h

2 [1–2]

3 [2–4]

<0.001

Pain score at 1. h

1 [0–1]

1 [1–2]

<0.001

Pain score at 6. h

0 [0–0]

1 [0–1]

<0.001
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Table 2. Pain scores in four subgroup comparisons.
SA+SC

SA+IC

PA+SC

PA+IC

p

Pain score at 0. h

1 [1–2]

2 [1–2]

2 [2–3.5]

3 [3–4]

<0.001

Pain score at 1. h

1 [0–1]

1 [0–1]

1 [0–2]

1 [1–2]

<0.001

Pain score at 6. h

0 [0–0]

0 [0–0]

0 [0–1]

0 [0–1]

<0.001

SA + SC, subcapsular anesthesia + subcostal procedure; SA + IC, subcapsular anesthesia + intercostal
procedure; PA + SC, pericapsular anesthesia + subcostal procedure; PA + IC, pericapsular anesthesia
+ intercostal procedure.

Figure 2. Comparison of the pain scores in the four subgroups: PA+IC pericapsular anesthetic and intercostal approach; PA+SC
pericapsular anesthetic and subcostal approach; SA+IC subcapsular anesthetic and intercostal approach; SA+SC subcapsular
anesthetic and subcostal approach.
Table 3. Correlation between the pain scores at 0, 1 and 6 h after the biopsy, and age and duration of the procedure.
Subcapsular

Pericapsular

Age

r

95% CI

P

r

95% CI

P

Pain score at 0. h

–0.007

(–0.157)–0.136

0.924

0.044

(–0.105)–0.197

0.570

Pain score at 1. h

–0.036

(–0.189)–0.109

0.636

0.033

(–0.108)–0.172

0.669

Pain score at 6. h

0.093

(–0.059)–0.238

0.226

0.054

(–0.003)–0.116

0.486

Procedure duration

r

95% CI

P

r

95% CI

P

Pain score at 0. h

–0.011

(–0.171)–0.152

0.894

0.210

0.036–0.379

0.010**

Pain score at 1. h

–0.080

(–0.260)–0.077

0.330

-0.008

(–0.175)–0.158

0.921

Pain score at 6. h

–0.105

(–0.267)–0.084

0.197

0.018

(–0.149)–0.192

0.823

**Correlation is significant at the 0.01 level (2-tailed).

assessment is recommended as a more definitive diagnostic
tool but requires invasive procedures such as PLB [15].
Pain is the most common complaint of patients after PLB
[2]. It has been reported that 69% of the patients complained
about the pain after PLB, with 1.5%–3% requiring
hospitalization [16,17]. Pain during and after the liver biopsy
is a subjective clinical finding, and it is challenging to address
because of its complex nature. The studies have shown a

correlation between reported pain and an increased number
of biopsies, a close relationship between complications
and percutaneous intervention, or biopsy needle thickness
[2]. However, the diagnostic accuracy of the histological
assessment is closely linked to the number of biopsy samples
and the adequacy of samples [18].
We randomized the patients undergoing US-guided
PLB into either the SA or the PA groups. Our results
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showed that the SA approach resulted in lower levels
of pain immediately after the procedure, 1 and 6 h
postoperatively. Although Pazeshki et al. reported no
difference in reported pain between parenchymal PLB
and PLB for focal mass lesion, it is not clear if either group
of patients received more analgesics before the biopsy
procedure because of anxiety [2]. More patients with PA
had a history of previous liver biopsy, but a history of
previous PLB has not been reported to be associated with
higher reported pain in previous studies. Therefore, we
suggest that a previous unpleasant biopsy experience may
lead to more reported pain in these patients. Interestingly,
the procedure duration was longer in the SA group than
the PA group, and it may be expected to result in more pain
due to several factors. This finding should be investigated
further before concluding that a prolonged procedure
duration for patients receiving SA may not affect the pain
experienced by patients.
We created four subgroups to evaluate the
contribution of the intercostal and subcostal routes to
the type of local anesthesia; subcapsular anesthesia +
subcostal procedure, subcapsular anesthesia + intercostal
procedure, pericapsular anesthesia + subcostal procedure
and pericapsular anesthesia + intercostal procedure.
Consistent with the results of previous reports, we found
that the subcostal procedure was associated with less
pain in addition to the effect of anesthesia type [2,3,6].
SA with subcostal procedure resulted in the lowest pain
scores for all three-time points, and PA with the intercostal
procedure was associated with the worst NRS scores. Our
study is the first, in terms of pain assessment, to investigate
the combination of route and anesthesia type in PLB. We
found no correlation between procedure duration and pain
in the SA group. However, there was a weak but significant
positive correlation between reported pain immediately
after the biopsy and duration in the PA group. Age did not
correlate with pain at three different points of evaluation
in both groups.
One of our study’s main finding was a significant
difference between the pain scores in favour of the
subcapsular anesthesia procedure. The critical point is that
patients with hepatitis are usually young, asymptomatic,
and need repeated biopsies for management [12].

Unfortunately, unpleasant experiences at the first biopsy
may result in patients being lost to follow up and, thus,
suboptimal treatment results. The second main finding
was that the subcapsular anesthesia/subcostal approach
combination resulted in significantly better pain scores.
Although previous studies have evaluated many factors,
our study is the first to evaluate the biopsy route and
anesthesia technique together [2,3,7].
A significant limitation of this study was that we did
not assess the level of anxiety before and after the biopsy
procedure. Anxiety level was associated with pain levels
and also correlated with an increase in analgesia use after
biopsy [5, 19]. There is a need for studies that evaluate
pre-procedure anxiety and the effect of either SA or PA
in PLB. Another limitation is the heterogeneity of the two
anesthesia groups in terms of several factors, including
needle type, needle thickness, biopsy indication, which
may be confounding for pain, and homogenization of the
groups may result in different results.
In summary, the results of our study suggest that
subcapsular anesthesia is superior to pericapsular
anesthesia. The use of the combination of SA and subcostal
liver biopsy route seems to be the best approach among
the four subgroups and resulted in the lowest pain scores.
Improving the patients’ experience of PLB by the type of
anesthesia and route of intervention may ameliorate the
negative effect of previous intolerable experiences for
patients and result in a greater willingness to undergo
further biopsies.
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